Researcher.Life Logo

Allergy and Asthma Proceedings : Impact Factor & More

eISSN: 1539-6304pISSN: 1088-5412

Key Metrics

CiteScore
4.9
Impact Factor
< 5
SJR
Q3Immunology and Allergy
SNIP
0.89
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Allergy and Asthma Proceedings

Allergy and Asthma Proceedings Journal Specifications

Overview
Publisher OCEAN SIDE PUBLICATIONS INC
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1996
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Allergy and Asthma Proceedings ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Allergy and Asthma Proceedings

Food allergy, biologic therapies, and diagnostic precision: Expanding frontiers in allergy and immunology.
  • 1 Jul 2026
  • Allergy and asthma proceedings
Predictors of delayed treatment-free remission with omalizumab in chronic spontaneous urticaria.
  • 1 Jul 2026
  • Allergy and asthma proceedings
Correlation of disease activity (Urticaria Activity Score over 7 Days) and quality of life (Chronic Urticaria Quality of Life Questionnaire) in patients with chronic spontaneous urticaria: A prospective observational study.
  • 1 Jul 2026
  • Allergy and asthma proceedings
Safety of dupilumab use during pregnancy: A composite evaluation of pregnancy outcomes.
  • 1 Jul 2026
  • Allergy and asthma proceedings
The digital front door: A national analysis of U.S. allergy and immunology fellowship program web sites.
  • 1 Jul 2026
  • Allergy and asthma proceedings
34-year-old female with cyclical abdominal pain and rash.
  • 1 Jul 2026
  • Allergy and asthma proceedings
Food allergy, biologic therapies, and diagnostic precision: Expanding frontiers in allergy and immunology.
  • 1 Jul 2026
  • Allergy and asthma proceedings
Predictors of delayed treatment-free remission with omalizumab in chronic spontaneous urticaria.
  • 1 Jul 2026
  • Allergy and asthma proceedings
Correlation of disease activity (Urticaria Activity Score over 7 Days) and quality of life (Chronic Urticaria Quality of Life Questionnaire) in patients with chronic spontaneous urticaria: A prospective observational study.
  • 1 Jul 2026
  • Allergy and asthma proceedings
Safety of dupilumab use during pregnancy: A composite evaluation of pregnancy outcomes.
  • 1 Jul 2026
  • Allergy and asthma proceedings
The digital front door: A national analysis of U.S. allergy and immunology fellowship program web sites.
  • 1 Jul 2026
  • Allergy and asthma proceedings
34-year-old female with cyclical abdominal pain and rash.
  • 1 Jul 2026
  • Allergy and asthma proceedings

FAQs on Allergy and Asthma Proceedings